Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)
| 25.54 Delayed Data As of Sep 29 |  +0.10 / +0.39%Today’s Change | 13.73 Today|||52-Week Range 37.75 | +50.59% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $678.8M |
Company Description
Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.
Contact Information
Arcturus Therapeutics Holdings, Inc. 10628 Science Center Drive San Diego California 92121 |
Employees
Shareholders
| Mutual fund holders | 61.12% |
| Other institutional | 22.90% |
| Individual stakeholders | 14.25% |
Top Executives
| Joseph E. Payne | President, Chief Executive Officer & Director |
| Padmanabh Chivukula | Secretary, Chief Operating & Scientific Officer |
| Andrew H. Sassine | Chief Financial Officer & Director |
| Dushyant B. Varshney | Chief Technology Office & Executive VP |
| Kevin T. Skol | Chief Business Officer |
